Monitoring immune response to immunotherapies in cancer patients with visact pet tracer
Ended Project Grant Awarded Last action
- Award ID
- R44CA221624
- Recipient
-
Cellsight Technologies, Inc. UEI E3UQXACGFR43
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,040,978
Award facts
- Assistance listing
- 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,020,835 | |
| Amendment | $21,105 | |
| Original award | $999,038 |
Quick answers
Who received award R44CA221624?
R44CA221624 was awarded to Cellsight Technologies, Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2017.
How much is award R44CA221624 worth?
$2,040,978 has been obligated on R44CA221624.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award